A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients

NCT00254436 PHASE3 TERMINATED

To demonstrate the effectiveness of epoetin alfa on reduction in red blood cell transfusions in gastric and rectal cancer patients undergoing preoperative chemoradiation therapy followed by surgery.

Details

Lead sponsor	M.D. Anderson Cancer Center
Phase	PHASE3
Status	TERMINATED
Enrolment	50
Start date	Wed Oct 31 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Gastrointestinal Cancer
• Rectal Cancer

Interventions

• Procrit (epoetin alfa)

Countries

United States